Equities research analysts at StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a research note issued to investors on Friday. The brokerage set a “buy” rating on the stock.
Mannatech Price Performance
Shares of MTEX stock opened at $7.53 on Friday. Mannatech has a 1 year low of $6.75 and a 1 year high of $10.51. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.62 and a current ratio of 1.17. The business’s fifty day moving average is $7.58 and its 200-day moving average is $7.58. The stock has a market cap of $14.18 million, a PE ratio of -8.46 and a beta of 1.17.
Mannatech (NASDAQ:MTEX – Get Free Report) last released its earnings results on Tuesday, August 13th. The company reported ($0.33) earnings per share (EPS) for the quarter. Mannatech had a negative return on equity of 11.87% and a negative net margin of 0.97%. The firm had revenue of $27.74 million for the quarter.
Insider Buying and Selling
Mannatech Company Profile
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Recommended Stories
- Five stocks we like better than Mannatech
- Learn Technical Analysis Skills to Master the Stock Market
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- What is a Death Cross in Stocks?
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- How to Start Investing in Real Estate
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.